Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
Cell Reports
|
May 11, 2024
The Janus kinase 1 is critical for pancreatic cancer initiation and progression
Hridaya Shrestha, Patrick D Rädler, Rayane Dennaoui, et al.
Journal of Hematology & Oncology
|
October 30, 2012
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy
Satyanarayana Rachagani, María P Torres, Sushil Kumar, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis
Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Cell Proliferation
|
June 30, 2022
Peripubertal requirement of Tsg101 in maintaining the integrity of membranous structures in mouse oocytes
Hyejin Shin, Dayoung Park, Jiyeon Kim, et al.
Gut
|
September 20, 2015
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis
Sabine Klein, Johanna Rick, Jennifer Lehmann, et al.
Blood
|
February 12, 2017
Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents
Malte Asshoff, Verena Petzer, Matthew R Warr, et al.
Nature Communications
|
April 10, 2015
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K Witkiewicz, Elizabeth A McMillan, Uthra Balaji, et al.
American Journal of Translational Research
|
March 23, 2019
Loss of Jak2 protects cardiac allografts from chronic rejection by attenuating Th1 response along with increased regulatory T cells
Hassan Mohammed Khair Ibrahim Higazi, Long He, Jing Fang, et al.
Breast Cancer Research : BCR
|
July 7, 2025
Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma
Rayane Dennaoui, Patrick D Rädler, Madison N Wicker, et al.
JCI Insight
|
July 21, 2017
Hepatic JAK2 protects against atherosclerosis through circulating IGF-1
Tharini Sivasubramaniyam, Stephanie A Schroer, Angela Li, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
Cell Reports
|
May 11, 2024
The Janus kinase 1 is critical for pancreatic cancer initiation and progression
Hridaya Shrestha, Patrick D Rädler, Rayane Dennaoui, et al.
Journal of Hematology & Oncology
|
October 30, 2012
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy
Satyanarayana Rachagani, María P Torres, Sushil Kumar, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis
Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
Cell Proliferation
|
June 30, 2022
Peripubertal requirement of Tsg101 in maintaining the integrity of membranous structures in mouse oocytes
Hyejin Shin, Dayoung Park, Jiyeon Kim, et al.
Gut
|
September 20, 2015
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis
Sabine Klein, Johanna Rick, Jennifer Lehmann, et al.
Blood
|
February 12, 2017
Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents
Malte Asshoff, Verena Petzer, Matthew R Warr, et al.
Nature Communications
|
April 10, 2015
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K Witkiewicz, Elizabeth A McMillan, Uthra Balaji, et al.
American Journal of Translational Research
|
March 23, 2019
Loss of Jak2 protects cardiac allografts from chronic rejection by attenuating Th1 response along with increased regulatory T cells
Hassan Mohammed Khair Ibrahim Higazi, Long He, Jing Fang, et al.
Breast Cancer Research : BCR
|
July 7, 2025
Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma
Rayane Dennaoui, Patrick D Rädler, Madison N Wicker, et al.
JCI Insight
|
July 21, 2017
Hepatic JAK2 protects against atherosclerosis through circulating IGF-1
Tharini Sivasubramaniyam, Stephanie A Schroer, Angela Li, et al.
Page
of 13